Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
BACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.
Saved in:
Main Authors: | Shaun K Morris, Upton D Allen, Sumit Gupta, Susan E Richardson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2012/957973 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro Assessment of Antifungal Caspofungin on Leishmania donovani Culture Isolation
by: Narayan Raj Bhattarai, et al.
Published: (2017-01-01) -
Inclusive mentorship of pediatric trainees: pediatric oncology as a microcosm
by: Sadhana Jackson, et al.
Published: (2025-01-01) -
Handbook of Pediatric Hematology and Oncology : Children's Hospital & Research Center Oakland /
by: Hastings , Caroline A.
Published: (2012) -
The importance of specific exercise therapy in pediatric oncology
by: Bianca Celine Schmidli, et al.
Published: (2025-01-01) -
Outcome of Bacteremia and Fungemia in Pediatric Oncology Patients
by: Joan L Robinson, et al.
Published: (2002-01-01)